• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支持性牙周治疗对侵袭性牙周炎患者再生手术治疗效果的影响。

The impact of supportive periodontal treatment on the outcome of regenerative surgical therapy in aggressive periodontitis patients.

出版信息

Quintessence Int. 2021;52(5):402-410. doi: 10.3290/j.qi.b912657.

DOI:10.3290/j.qi.b912657
PMID:33491386
Abstract

Objective: The aim was to evaluate the efficacy of periodontal regenerative therapy using enamel matrix derivatives (EMDs) in aggressive periodontitis patients, and to determine the contribution of maintenance via periodic supportive periodontal treatment. Method and materials: In total, 28 patients were evaluated, comprising 74 intrabony sites. In 50 sites EMD gel was applied, and in 24 sites EMD was combined with deproteinized bovine xenograft. Patients were assigned to a supportive periodontal treatment program; 18 patients fulfilled the program, defined as the well-maintained (WM) group; 10 did not comply, defined as the nonmaintained (NM) group. Probing depth (PD), clinical attachment level (CAL), and radiographic bone level (BL) were recorded. Data were compared presurgically (T0), 6 months postsurgery (T1), and 3 to 10 years posttreatment (T2). Results: Both surgical modalities achieved similar PD reduction, CAL gain, and BL gain, maintained over time. T1 to T2 showed a mean gain/loss of 0.21 ± 0.5 mm and 0.04 ± 1.1 mm, and -0.65 ± 3.0 mm and -0.73 ± 3.0 mm for PD and CAL, respectively, at the WM/NM groups, respectively. BL gain was 21.6% and 11.5% for the WM/NM groups, respectively (P < .05). The courses of the PD, CAL, and BL differed between the WM and NM groups during the observation periods (P < .05). Conclusion: Periodontal regeneration via EMD with/without the combination of deproteinized bovine xenograft can be maintained in aggressive periodontitis cases. It appears that periodic supportive periodontal treatment is a determinant factor in achieving this task.

摘要

目的

评估使用釉基质衍生物(EMD)进行牙周再生治疗在侵袭性牙周炎患者中的疗效,并确定通过定期的辅助牙周治疗来维持疗效的作用。方法和材料:共评估了 28 名患者,共涉及 74 个骨内位点。其中 50 个位点应用 EMD 凝胶,24 个位点应用 EMD 联合脱蛋白牛异种移植物。患者被分配到辅助牙周治疗方案中;18 名患者完成了方案,定义为维护良好(WM)组;10 名患者未完成方案,定义为未维护(NM)组。记录探诊深度(PD)、临床附着水平(CAL)和放射影像学骨水平(BL)。数据在术前(T0)、术后 6 个月(T1)和治疗后 3 至 10 年(T2)进行比较。结果:两种手术方式均能达到类似的 PD 减少、CAL 增加和 BL 增加,并能长期维持。T1 到 T2 显示 WM/NM 组的平均增益/损失分别为 0.21±0.5mm 和 0.04±1.1mm,以及-0.65±3.0mm 和-0.73±3.0mm,用于 PD 和 CAL。WM/NM 组的 BL 增益分别为 21.6%和 11.5%(P<.05)。在观察期间,WM 和 NM 组的 PD、CAL 和 BL 变化轨迹不同(P<.05)。结论:在侵袭性牙周炎病例中,使用 EMD 进行牙周再生治疗,联合或不联合脱蛋白牛异种移植物,可以维持疗效。定期的辅助牙周治疗似乎是实现这一目标的决定因素。

相似文献

1
The impact of supportive periodontal treatment on the outcome of regenerative surgical therapy in aggressive periodontitis patients.支持性牙周治疗对侵袭性牙周炎患者再生手术治疗效果的影响。
Quintessence Int. 2021;52(5):402-410. doi: 10.3290/j.qi.b912657.
2
Deproteinized bovine bone in association with guided tissue regeneration or enamel matrix derivatives procedures in aggressive periodontitis patients: a 1-year retrospective study.去蛋白牛骨联合引导组织再生术或釉基质衍生物治疗侵袭性牙周炎患者:一项1年的回顾性研究。
J Clin Periodontol. 2015 Jun;42(6):547-56. doi: 10.1111/jcpe.12413. Epub 2015 May 30.
3
Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.使用引导组织再生术或釉基质衍生物治疗骨内缺损:一项为期3年的前瞻性随机临床研究。
J Periodontol. 2008 Dec;79(12):2281-9. doi: 10.1902/jop.2008.080135.
4
Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study.使用釉基质蛋白和引导组织再生治疗骨内缺损。一项前瞻性对照临床研究。
J Clin Periodontol. 2001 May;28(5):397-403. doi: 10.1034/j.1600-051x.2001.028005397.x.
5
Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.单独使用或与牛源异种移植物联合使用牙釉质基质衍生物治疗人类牙周骨缺损的临床比较。
J Periodontol. 2002 Apr;73(4):433-40. doi: 10.1902/jop.2002.73.4.433.
6
Long-term clinical outcomes of periodontal regeneration with enamel matrix derivative: A retrospective cohort study with a mean follow-up of 10 years.用釉基质衍生物进行牙周再生的长期临床疗效:一项平均随访 10 年的回顾性队列研究。
J Periodontol. 2022 Apr;93(4):548-559. doi: 10.1002/JPER.21-0347. Epub 2021 Sep 8.
7
Clinical outcomes following regenerative therapy of non-contained intrabony defects using a deproteinized bovine bone mineral combined with either enamel matrix derivative or collagen membrane.使用脱蛋白牛骨矿物质联合釉基质衍生物或胶原膜对非包容性骨内缺损进行再生治疗后的临床结果
J Periodontol. 2014 Oct;85(10):1342-50. doi: 10.1902/jop.2014.130420. Epub 2014 May 16.
8
Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate.单独使用或联合使用釉基质衍生物及双相磷酸钙治疗骨内牙周缺损的四年疗效观察。
Clin Oral Investig. 2012 Aug;16(4):1191-7. doi: 10.1007/s00784-011-0611-2. Epub 2011 Sep 1.
9
Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.采用釉基质蛋白衍生物联合天然骨矿物质或 β-磷酸三钙治疗骨内缺损 10 年的疗效观察。
J Periodontol. 2013 Jun;84(6):749-57. doi: 10.1902/jop.2012.120238. Epub 2012 Aug 8.
10
A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.单独使用牛源异种移植物以及联合牙釉质基质衍生物治疗人类牙周骨缺损的临床比较。
J Periodontol. 2002 Apr;73(4):423-32. doi: 10.1902/jop.2002.73.4.423.

引用本文的文献

1
A Modern Approach to Treat Molar/Incisor Pattern Periodontitis-Review.治疗磨牙/切牙型牙周炎的现代方法——综述
J Clin Med. 2023 Sep 21;12(18):6107. doi: 10.3390/jcm12186107.
2
Oral Health, Antimicrobials and Care for Patients With Chronic Oral Diseases - A Review of Knowledge and Treatment Strategies.口腔健康、抗菌药物与慢性口腔疾病患者的护理——知识与治疗策略综述
Front Oral Health. 2022 Jun 7;3:866695. doi: 10.3389/froh.2022.866695. eCollection 2022.